Mirum Pharmaceuticals, Inc.
MIRM
$100.64
$1.871.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1,047.02% | -5,283.63% | 75.91% | 120.41% | 76.21% |
| Total Depreciation and Amortization | 14.53% | 13.58% | 0.30% | 0.12% | 3.45% |
| Total Amortization of Deferred Charges | 54.10% | 4.85% | 4.81% | 4.48% | 4.91% |
| Total Other Non-Cash Items | 209.34% | 2,477.85% | 38.49% | 39.73% | 38.14% |
| Change in Net Operating Assets | -513.48% | 1,004.83% | -732.76% | 1,085.80% | -519.45% |
| Cash from Operations | -467.54% | -11,565.63% | 219.71% | 896.01% | 416.59% |
| Capital Expenditure | 81.75% | -1,519.51% | -2,900.00% | -3.31% | 83.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,371.31% | 32.24% | 142.97% | 88.57% | 91.00% |
| Cash from Investing | -2,324.47% | 28.29% | 56.94% | 87.65% | 90.93% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -45.12% | 4,282.43% | 68.52% | 316.67% | 19.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,333.68% | 4,147.19% | 68.52% | 316.67% | 19.16% |
| Foreign Exchange rate Adjustments | -161.68% | -220.57% | 70.41% | 296.59% | 1,970.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -64.40% | 366.59% | 3,461.37% | 633.60% | 123.58% |